Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage-Reference-Cited by-同舟云学术

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage

Published:2022-07-21 Issue:16 Volume:26 Page:4613-4623
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Huang Jianfang¹²,Mao Yuling¹,Li Quanxin³,Hong Honghai⁴,Tang Ni¹,Kang Xiangjin¹,Huang Yuling¹,Liu Jianqiao¹,Gong Qing³,Yao Yachao⁵,Li Lei¹⁶^ORCID

Affiliation:

1. Key Laboratory for Major Obstetric Diseases of Guangdong Province Department of Obstetrics and Gynecology, Center for Reproductive Medicine The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China

2. Department of Reproductive Medicine Ganzhou People's Hospital Ganzhou Jiangxi China

3. Department of Biochemistry and Molecular Biology, GMU‐GIBH Joint School of Life Sciences Guangzhou Medical University Guangzhou China

4. Department of Clinical Laboratory The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China

5. Department of Laboratory Medicine Guangdong Second Provincial General Hospital Guangzhou China

6. Key Laboratory for Reproductive Medicine of Guangdong Province The Third Affiliated Hospital of Guangzhou Medical University Guangzhou China

Funder

National Nature Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17491

Reference43 articles.

1. Neurovascular Complications of Ovarian Hyperstimulation Syndrome (OHSS): From Pathophysiology to Recent Treatment Options

2. Ovarian hyperstimulation syndrome

3. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

4. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome

5. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study;Diagnostics;2024-07-18

2. Vitamin D3 reduces the symptoms of ovarian hyperstimulation syndrome in mice and inhibits the release of granulosa cell angiogenic factor through pentraxin 3;In Vitro Cellular & Developmental Biology - Animal;2024-04

3. The Effect and Possible Mechanism of Kallistatin in Protecting against Endometrial Fibrosis;J BIOL REG HOMEOS AG;2023

4. EGR1 Promotes Ovarian Hyperstimulation Syndrome Through Upregulation of SOX9 Expression;Cell Transplantation;2023-01